The Psychedelic Therapy Podcast25 Sep 2020

Lynn Marie Morski: Introducing the Psychedelic Medicine Association

How will doctors who don’t know about psychedelic therapies, learn to be receptive to these innovative compounds as valuable tools for their patients? Dr. Lynn Marie Morski, host of the Plant Medicine Podcast, has a brilliant idea–to form an association dedicated to educating medical practitioners about psychedelics.

On today’s episode, we discuss why Lynn Marie created the Psychedelic Medicine Association. We talk about what it means to create a coalition of ethically aligned actors and how to advance equal access to entheogenic compounds. Lynn Marie shares her entrepreneurial challenges and her dreams about where this association could go in the next 5 to 10 years.

As you’ll learn on the show, Lynn Marie has quite an impressive background. She is a physician, an attorney, a podcaster, and the author of Quitting by Design. She works with the Veterans Administration and hosts the Plant Medicine Podcast.

LINKS

TIMESTAMPS

:06 - How psychedelic medicine can change the way we believe we must achieve to be loved
:14 - Lynn Marie’s successful Plant Medicine Podcast
:23 - Why Lynn Marie created an association to educate doctors on the value of psychedelics
:29 - Creating coalitions of ethically aligned actors and equal access to psychedelic
:40 - Where Lynn Marie sees the Psychedelic Medicine Association in 5-10 years
:45 - Founding members, Lynn Marie’s team, and how you can get involved.
:53 - Lynn Marie speaks directly to psychedelic practitioners

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(64)

Ismail Lourido Ali (MAPS): The Work No Executive Order Can Do

"We can pass 10 executive orders. We can put $500 million for drug development. And if we don't have people who are willing to hold that space... we're not going to get anywhere." - Ismail Lourido Ali...

21 Apr 1h 10min

Robin Arnott & Sandeep Prakash: Training for Psychedelic Surrender

Can we practice the art of surrender before the first dose?Today on the show Robin Arnott and Dr. Sandeep Prakash explain how SoundSelf evolved from a VR curiosity into a clinically oriented tool that...

25 Apr 202555min

Joshua White: Who You Gonna Call? Fireside

Imagine you’re in the middle of a psychedelic journey—things are getting intense, and you just need someone to talk to. That’s whereFireside Project comes in. As the world’s first psychedelic peer sup...

13 Feb 20251h 14min

Tom Feegel: Ibogaine for Cognitive Enhancement

A month ago, I had the privilege of visiting Beond in Cancun, Mexico to experience an ibogaine treatment for cognitive enhancement. Today, I’m joined by Beond CEO Tom Feegel to discuss how this remark...

27 Jan 20251h 6min

Juan Pablo Capello: A Wakeup Call for Ketamine Telehealth Companies

Today, I’m joined by Juan Pablo Capello, co-founder and former CEO of New Life Health, a telehealth ketamine therapy service launched in 2021. Juan Pablo has raised concerns about low standards of car...

20 Nov 20241h 4min

Natalie Lyla Ginsberg (MAPS): The FDA, MDMA, and the Future of Psychedelic Therapy

Today, we’re exploring a critical issue facing the field of psychedelic medicine: the recent FDA rejection of MAPS’ clinical trials to reschedule MDMA for therapeutic use. This setback affects many of...

28 Okt 20241h 3min

Tricia Eastman & Joseph Barsuglia: Ibogaine is Miracle Grow for the Brain

Today we’re doing something a little different. I’m re-releasing an episode from my personal podcast, Life is a Festival, because it remains one of my favorite interviews ever. This conversation, orig...

18 Okt 20241h 9min

Jennifer Tippett: Understanding Private Practice vs Clinical Trials

After the shocking decision of an advisory committee recommendation that the FDA reject MDMA as a treatment for post-traumatic stress disorder, I wanted to speak to someone who understands the differe...

8 Aug 202446min